Treating Caries Chemically (Without The Filling)
Saturday, October 3rd, 2026
8:00 AM - 11:00 AM
Credits: 3
Audience: Dentists, Hygienists, Assistants, Admin Staff, Students
Teaching Methods: Lecture
Prerequisites: No prior level of skill, knowledge, or experience is required for participation in this course.
COURSE DESCRIPTION: Clinical practice today uses scientifically sound evidence-based approaches. There is a noticeable shift to the caries treatment paradigm by better preventing and managing caries as a disease at the patient level. Person-centered care is an approach where the individual in your dental chair is treated as a person rather than a patient; where their personal preferences and shared decisions drive clinical treatment options.
This course will address current trends in caries risk management at the patient level utilizing an evidence-based, person-centered methodology.
The presentation provides an excellent update relevant to clinical applications for the dentist, hygienist, assistant, and front office.
LEARNING OBJECTIVES:
At the conclusion of this course, attendees will be able to:
◆ Properly perform a caries risk assessment
◆ Propose evidence-based treatment options using products to the patient
◆ Understand the biological, chemical and mechanical aspects of caries disease
SPEAKER: Douglas Young, DDS, EdD, MS, MBA
Dr. Young is a professor emeritus at the University of the Pacific where he is an active and ardent educator in the field of minimally invasive dentistry and cariology. He was one of the founders of the CAMBRA (Caries Management By Risk Assessment) Coalition, American Dental Education Association Cariology Section, and the American Academy of Cariology. Dr. Young has served on the ADA Council of Scientific Affairs and is currently a cariology consultant for the ADA. He has presented at congresses and universities around the world and published in numerous peer-reviewed dental journals and textbooks on caries management using minimal invasive dentistry, silver fluoride, and glass ionomer restoratives.
FINANCIAL DISCLOSURE: Dr. Young is a shareholder at Oral Biotech. He has received previous honorarium support form GC America, Oral BioTech, and Elevate Oral.